|
KR20200134153A
|
|
Novel peptide compound or pharmaceutically acceptable salt thereof
|
|
KR20210010266A
|
|
Preparation methode of cyclic peptide compound, and cyclic peptide compound prepared by the methode
|
|
KR20200098906A
|
|
Novel latanoprost intermediate and method for preparing latanoprost with high purity
|
|
KR20200084713A
|
|
Tenofovir alafenamide succinate salt, preparation methode of thereof and phamaceutical composition comprising thereof
|
|
KR20200079883A
|
|
Pharmaceutical composition comprising novel linagliptin pocolinate
|
|
KR20200064796A
|
|
Method for the preparation of high purity Palonosetron intermediates
|
|
KR20200033698A
|
|
Salts compound of edoxaban and preparation methode of the same
|
|
KR20190128840A
|
|
Preparation methode of 5-phenyl pentyl hexahydro cyclopentafuran compounds and cycloheptanoate compounds
|
|
KR20190124536A
|
|
Preparation methode of 5-phenyl pentyl hexahydro cyclopentafuran compounds and cycloheptanoate compounds
|
|
KR20190019701A
|
|
Preparation methode of quinazoline derivatives or an intermediate of the same
|
|
KR20180123851A
|
|
Novel crystal form of lenalidomide and preparation of the same
|
|
KR20170024602A
|
|
Novel Crystal Form of Atorvastatin Hemi-Calcium, Hydrate thereof, and Method of Producing the Same
|
|
KR20170085270A
|
|
Cefuroxime axetil granule composition containing citric acid
|
|
KR20170048878A
|
|
New process for preparing Citalopram and Escitalopram
|
|
KR20170029141A
|
|
Method for the preparation of high purity Bazedoxifene Acetate
|
|
KR20160105557A
|
|
Refine Method for the preparation of high purity Olanzapine
|
|
WO2015122702A1
|
|
Novel crystalline form of bortezomib and preparation method thereof
|
|
KR20160061542A
|
|
A Novel Method for Separation of Luliconazole Isomers
|
|
KR20160039736A
|
|
Stable crystalline form botezomib
|
|
KR20160013412A
|
|
Method for the preparation of high purity Tenofovir Disoproxil Fumarate
|
